Clinical Research Trials Archive – Closed Trials

This is our archive of closed clinical trials, which means that they are no longer accepting new participants or have been concluded. Once a research facility has chosen to close the study, it is sorted into the GPS archive by indication. If you are interested in enrolling in a clinical trial, then please browse our list of active clinical studies.

Zip code

Condition


Search Radius:25 Miles
  • 5
  • 10
  • 15
  • 20
  • 25
  • 30
  • 40
  • 50
  • 100
  • 500
  • All

We've found
15,419
archived clinical trials in
Pulmonary

Safety Study of Arformoterol Tartrate Inhalation Solution in Chronic Obstructive Pulmonary Disease (COPD) Subjects
A Large Simple Safety Study of Arformoterol Tartrate Inhalation Solution in Subjects With Chronic Obstructive Pulmonary Disease
Status: Archived
Physician PrimeCare Research
mi
from
San Antonio, TX
Safety Study of Arformoterol Tartrate Inhalation Solution in Chronic Obstructive Pulmonary Disease (COPD) Subjects
A Large Simple Safety Study of Arformoterol Tartrate Inhalation Solution in Subjects With Chronic Obstructive Pulmonary Disease
Status: Archived
Updated: 1/1/1970
Physician PrimeCare Research
mi
from
San Antonio, TX
Safety Study of Arformoterol Tartrate Inhalation Solution in Chronic Obstructive Pulmonary Disease (COPD) Subjects
A Large Simple Safety Study of Arformoterol Tartrate Inhalation Solution in Subjects With Chronic Obstructive Pulmonary Disease
Status: Archived
Diagnostics Research Group
mi
from
San Antonio, TX
Safety Study of Arformoterol Tartrate Inhalation Solution in Chronic Obstructive Pulmonary Disease (COPD) Subjects
A Large Simple Safety Study of Arformoterol Tartrate Inhalation Solution in Subjects With Chronic Obstructive Pulmonary Disease
Status: Archived
Updated: 1/1/1970
Diagnostics Research Group
mi
from
San Antonio, TX
Safety Study of Arformoterol Tartrate Inhalation Solution in Chronic Obstructive Pulmonary Disease (COPD) Subjects
A Large Simple Safety Study of Arformoterol Tartrate Inhalation Solution in Subjects With Chronic Obstructive Pulmonary Disease
Status: Archived
SouthEast Research Institute
mi
from
Webster, TX
Safety Study of Arformoterol Tartrate Inhalation Solution in Chronic Obstructive Pulmonary Disease (COPD) Subjects
A Large Simple Safety Study of Arformoterol Tartrate Inhalation Solution in Subjects With Chronic Obstructive Pulmonary Disease
Status: Archived
Updated: 1/1/1970
SouthEast Research Institute
mi
from
Webster, TX
Safety Study of Arformoterol Tartrate Inhalation Solution in Chronic Obstructive Pulmonary Disease (COPD) Subjects
A Large Simple Safety Study of Arformoterol Tartrate Inhalation Solution in Subjects With Chronic Obstructive Pulmonary Disease
Status: Archived
National Clinical Resources, Inc.
mi
from
Provo, UT
Safety Study of Arformoterol Tartrate Inhalation Solution in Chronic Obstructive Pulmonary Disease (COPD) Subjects
A Large Simple Safety Study of Arformoterol Tartrate Inhalation Solution in Subjects With Chronic Obstructive Pulmonary Disease
Status: Archived
Updated: 1/1/1970
National Clinical Resources, Inc.
mi
from
Provo, UT
Safety Study of Arformoterol Tartrate Inhalation Solution in Chronic Obstructive Pulmonary Disease (COPD) Subjects
A Large Simple Safety Study of Arformoterol Tartrate Inhalation Solution in Subjects With Chronic Obstructive Pulmonary Disease
Status: Archived
Utah Clinical Trials
mi
from
Salt Lake City, UT
Safety Study of Arformoterol Tartrate Inhalation Solution in Chronic Obstructive Pulmonary Disease (COPD) Subjects
A Large Simple Safety Study of Arformoterol Tartrate Inhalation Solution in Subjects With Chronic Obstructive Pulmonary Disease
Status: Archived
Updated: 1/1/1970
Utah Clinical Trials
mi
from
Salt Lake City, UT
Safety Study of Arformoterol Tartrate Inhalation Solution in Chronic Obstructive Pulmonary Disease (COPD) Subjects
A Large Simple Safety Study of Arformoterol Tartrate Inhalation Solution in Subjects With Chronic Obstructive Pulmonary Disease
Status: Archived
Charlottesville Medical Research
mi
from
, VA
Safety Study of Arformoterol Tartrate Inhalation Solution in Chronic Obstructive Pulmonary Disease (COPD) Subjects
A Large Simple Safety Study of Arformoterol Tartrate Inhalation Solution in Subjects With Chronic Obstructive Pulmonary Disease
Status: Archived
Updated: 1/1/1970
Charlottesville Medical Research
mi
from
, VA
Safety Study of Arformoterol Tartrate Inhalation Solution in Chronic Obstructive Pulmonary Disease (COPD) Subjects
A Large Simple Safety Study of Arformoterol Tartrate Inhalation Solution in Subjects With Chronic Obstructive Pulmonary Disease
Status: Archived
Manassas Clinical Research Center
mi
from
Manassas, VA
Safety Study of Arformoterol Tartrate Inhalation Solution in Chronic Obstructive Pulmonary Disease (COPD) Subjects
A Large Simple Safety Study of Arformoterol Tartrate Inhalation Solution in Subjects With Chronic Obstructive Pulmonary Disease
Status: Archived
Updated: 1/1/1970
Manassas Clinical Research Center
mi
from
Manassas, VA
Safety Study of Arformoterol Tartrate Inhalation Solution in Chronic Obstructive Pulmonary Disease (COPD) Subjects
A Large Simple Safety Study of Arformoterol Tartrate Inhalation Solution in Subjects With Chronic Obstructive Pulmonary Disease
Status: Archived
Dominion Medical Associates
mi
from
Richmond, VA
Safety Study of Arformoterol Tartrate Inhalation Solution in Chronic Obstructive Pulmonary Disease (COPD) Subjects
A Large Simple Safety Study of Arformoterol Tartrate Inhalation Solution in Subjects With Chronic Obstructive Pulmonary Disease
Status: Archived
Updated: 1/1/1970
Dominion Medical Associates
mi
from
Richmond, VA
Safety Study of Arformoterol Tartrate Inhalation Solution in Chronic Obstructive Pulmonary Disease (COPD) Subjects
A Large Simple Safety Study of Arformoterol Tartrate Inhalation Solution in Subjects With Chronic Obstructive Pulmonary Disease
Status: Archived
Pulmonary Associates of Richmond, Inc
mi
from
Richmond, VA
Safety Study of Arformoterol Tartrate Inhalation Solution in Chronic Obstructive Pulmonary Disease (COPD) Subjects
A Large Simple Safety Study of Arformoterol Tartrate Inhalation Solution in Subjects With Chronic Obstructive Pulmonary Disease
Status: Archived
Updated: 1/1/1970
Pulmonary Associates of Richmond, Inc
mi
from
Richmond, VA
Safety Study of Arformoterol Tartrate Inhalation Solution in Chronic Obstructive Pulmonary Disease (COPD) Subjects
A Large Simple Safety Study of Arformoterol Tartrate Inhalation Solution in Subjects With Chronic Obstructive Pulmonary Disease
Status: Archived
Pulmonary Associates of Richmond, Inc.
mi
from
Richmond, VA
Safety Study of Arformoterol Tartrate Inhalation Solution in Chronic Obstructive Pulmonary Disease (COPD) Subjects
A Large Simple Safety Study of Arformoterol Tartrate Inhalation Solution in Subjects With Chronic Obstructive Pulmonary Disease
Status: Archived
Updated: 1/1/1970
Pulmonary Associates of Richmond, Inc.
mi
from
Richmond, VA
Safety Study of Arformoterol Tartrate Inhalation Solution in Chronic Obstructive Pulmonary Disease (COPD) Subjects
A Large Simple Safety Study of Arformoterol Tartrate Inhalation Solution in Subjects With Chronic Obstructive Pulmonary Disease
Status: Archived
Pulmonary Consultants, Pllc
mi
from
Tacoma, WA
Safety Study of Arformoterol Tartrate Inhalation Solution in Chronic Obstructive Pulmonary Disease (COPD) Subjects
A Large Simple Safety Study of Arformoterol Tartrate Inhalation Solution in Subjects With Chronic Obstructive Pulmonary Disease
Status: Archived
Updated: 1/1/1970
Pulmonary Consultants, Pllc
mi
from
Tacoma, WA
Effect of Supplemental Vitamin D on Skeletal Muscle Function in Chronic Obstructive Pulmonary Disease (COPD) Patients
Effect of Supplemental Vitamin D on Skeletal Muscle Function in COPD Patients.
Status: Archived
Veterans Affairs Medical Center - Long Beach
mi
from
Long Beach, CA
Effect of Supplemental Vitamin D on Skeletal Muscle Function in Chronic Obstructive Pulmonary Disease (COPD) Patients
Effect of Supplemental Vitamin D on Skeletal Muscle Function in COPD Patients.
Status: Archived
Updated: 1/1/1970
Veterans Affairs Medical Center - Long Beach
mi
from
Long Beach, CA
Complex Sleep Apnea Syndrome (CompSAS) Resolution Study
Is Adaptive Servo-Ventilation Therapeutically More Effective Than Continuous Positive Airway Pressure In Treating Complex Sleep Apnea Syndrome?
Status: Archived
REM Medical
mi
from
Phoenix, AZ
Complex Sleep Apnea Syndrome (CompSAS) Resolution Study
Is Adaptive Servo-Ventilation Therapeutically More Effective Than Continuous Positive Airway Pressure In Treating Complex Sleep Apnea Syndrome?
Status: Archived
Updated: 1/1/1970
REM Medical
mi
from
Phoenix, AZ
Complex Sleep Apnea Syndrome (CompSAS) Resolution Study
Is Adaptive Servo-Ventilation Therapeutically More Effective Than Continuous Positive Airway Pressure In Treating Complex Sleep Apnea Syndrome?
Status: Archived
Northwestern University
mi
from
Chicago, IL
Complex Sleep Apnea Syndrome (CompSAS) Resolution Study
Is Adaptive Servo-Ventilation Therapeutically More Effective Than Continuous Positive Airway Pressure In Treating Complex Sleep Apnea Syndrome?
Status: Archived
Updated: 1/1/1970
Northwestern University
mi
from
Chicago, IL
Complex Sleep Apnea Syndrome (CompSAS) Resolution Study
Is Adaptive Servo-Ventilation Therapeutically More Effective Than Continuous Positive Airway Pressure In Treating Complex Sleep Apnea Syndrome?
Status: Archived
North Shore University Health Systems
mi
from
Evanston, IL
Complex Sleep Apnea Syndrome (CompSAS) Resolution Study
Is Adaptive Servo-Ventilation Therapeutically More Effective Than Continuous Positive Airway Pressure In Treating Complex Sleep Apnea Syndrome?
Status: Archived
Updated: 1/1/1970
North Shore University Health Systems
mi
from
Evanston, IL
Complex Sleep Apnea Syndrome (CompSAS) Resolution Study
Is Adaptive Servo-Ventilation Therapeutically More Effective Than Continuous Positive Airway Pressure In Treating Complex Sleep Apnea Syndrome?
Status: Archived
Mayo Center for Sleep Medicine, Mayo Clinic
mi
from
Rochester, MN
Complex Sleep Apnea Syndrome (CompSAS) Resolution Study
Is Adaptive Servo-Ventilation Therapeutically More Effective Than Continuous Positive Airway Pressure In Treating Complex Sleep Apnea Syndrome?
Status: Archived
Updated: 1/1/1970
Mayo Center for Sleep Medicine, Mayo Clinic
mi
from
Rochester, MN
Complex Sleep Apnea Syndrome (CompSAS) Resolution Study
Is Adaptive Servo-Ventilation Therapeutically More Effective Than Continuous Positive Airway Pressure In Treating Complex Sleep Apnea Syndrome?
Status: Archived
Center for Sleep Medicine
mi
from
Lafayette Hill, PA
Complex Sleep Apnea Syndrome (CompSAS) Resolution Study
Is Adaptive Servo-Ventilation Therapeutically More Effective Than Continuous Positive Airway Pressure In Treating Complex Sleep Apnea Syndrome?
Status: Archived
Updated: 1/1/1970
Center for Sleep Medicine
mi
from
Lafayette Hill, PA
Complex Sleep Apnea Syndrome (CompSAS) Resolution Study
Is Adaptive Servo-Ventilation Therapeutically More Effective Than Continuous Positive Airway Pressure In Treating Complex Sleep Apnea Syndrome?
Status: Archived
SleepMed of South Carolina
mi
from
Columbia, SC
Complex Sleep Apnea Syndrome (CompSAS) Resolution Study
Is Adaptive Servo-Ventilation Therapeutically More Effective Than Continuous Positive Airway Pressure In Treating Complex Sleep Apnea Syndrome?
Status: Archived
Updated: 1/1/1970
SleepMed of South Carolina
mi
from
Columbia, SC
Exploratory Study of Potential Pulmonary Aspiration Markers From Bronchoalveolar Lavage Fluid
Exploratory Study of Potential Pulmonary Aspiration Markers From Bronchoalveolar Lavage Fluid"
Status: Archived
Mayo Clinic - Division of Nephrology
mi
from
Rochester, MN
Exploratory Study of Potential Pulmonary Aspiration Markers From Bronchoalveolar Lavage Fluid
Exploratory Study of Potential Pulmonary Aspiration Markers From Bronchoalveolar Lavage Fluid"
Status: Archived
Updated: 1/1/1970
Mayo Clinic - Division of Nephrology
mi
from
Rochester, MN
Pre-Operative Polysomnography Assessment of Cardiac Surgery Inpatients
Pre-Operative PSG Assessment of Cardiac Surgery Inpatients
Status: Archived
Johns Hopkins University
mi
from
Baltimore, MD
Pre-Operative Polysomnography Assessment of Cardiac Surgery Inpatients
Pre-Operative PSG Assessment of Cardiac Surgery Inpatients
Status: Archived
Updated: 1/1/1970
Johns Hopkins University
mi
from
Baltimore, MD
Pre-Operative Polysomnography Assessment of Cardiac Surgery Inpatients
Pre-Operative PSG Assessment of Cardiac Surgery Inpatients
Status: Archived
The Cleveland Clinic
mi
from
Cleveland, OH
Pre-Operative Polysomnography Assessment of Cardiac Surgery Inpatients
Pre-Operative PSG Assessment of Cardiac Surgery Inpatients
Status: Archived
Updated: 1/1/1970
The Cleveland Clinic
mi
from
Cleveland, OH
Biomarkers in the Evaluation of Chronic Lung Disease
Biomarkers in the Evaluation of Chronic Lung Disease
Status: Archived
Interstitial Lung Disease and Pulmonary Hypertension Programs
mi
from
New Hyde Park, NY
Biomarkers in the Evaluation of Chronic Lung Disease
Biomarkers in the Evaluation of Chronic Lung Disease
Status: Archived
Updated: 1/1/1970
Interstitial Lung Disease and Pulmonary Hypertension Programs
mi
from
New Hyde Park, NY
Triplet Combination First Line Treatment in Non Small Cell Lung Cancer (NSCLC)
Phase II Study of a Triplet Combination of CBP501, Pemetrexed and Cisplatin as First Line Treatment in Patients With Locally Advanced (Stage IIIB With Malignant Pleural Effusion or Pericardial Effusion) or Metastatic (Stage IV) Non-squamous Non Small Cell Lung Cancer (NSCLC)
Status: Archived
Nevada Cancer Institute
mi
from
Las Vegas, NV
Triplet Combination First Line Treatment in Non Small Cell Lung Cancer (NSCLC)
Phase II Study of a Triplet Combination of CBP501, Pemetrexed and Cisplatin as First Line Treatment in Patients With Locally Advanced (Stage IIIB With Malignant Pleural Effusion or Pericardial Effusion) or Metastatic (Stage IV) Non-squamous Non Small Cell Lung Cancer (NSCLC)
Status: Archived
Updated: 1/1/1970
Nevada Cancer Institute
mi
from
Las Vegas, NV
Triplet Combination First Line Treatment in Non Small Cell Lung Cancer (NSCLC)
Phase II Study of a Triplet Combination of CBP501, Pemetrexed and Cisplatin as First Line Treatment in Patients With Locally Advanced (Stage IIIB With Malignant Pleural Effusion or Pericardial Effusion) or Metastatic (Stage IV) Non-squamous Non Small Cell Lung Cancer (NSCLC)
Status: Archived
Penn State Milton S. Hershey Medical Center
mi
from
Hershey, PA
Triplet Combination First Line Treatment in Non Small Cell Lung Cancer (NSCLC)
Phase II Study of a Triplet Combination of CBP501, Pemetrexed and Cisplatin as First Line Treatment in Patients With Locally Advanced (Stage IIIB With Malignant Pleural Effusion or Pericardial Effusion) or Metastatic (Stage IV) Non-squamous Non Small Cell Lung Cancer (NSCLC)
Status: Archived
Updated: 1/1/1970
Penn State Milton S. Hershey Medical Center
mi
from
Hershey, PA
Triplet Combination First Line Treatment in Non Small Cell Lung Cancer (NSCLC)
Phase II Study of a Triplet Combination of CBP501, Pemetrexed and Cisplatin as First Line Treatment in Patients With Locally Advanced (Stage IIIB With Malignant Pleural Effusion or Pericardial Effusion) or Metastatic (Stage IV) Non-squamous Non Small Cell Lung Cancer (NSCLC)
Status: Archived
Mary Crowley Cancer Research Center
mi
from
Dallas, TX
Triplet Combination First Line Treatment in Non Small Cell Lung Cancer (NSCLC)
Phase II Study of a Triplet Combination of CBP501, Pemetrexed and Cisplatin as First Line Treatment in Patients With Locally Advanced (Stage IIIB With Malignant Pleural Effusion or Pericardial Effusion) or Metastatic (Stage IV) Non-squamous Non Small Cell Lung Cancer (NSCLC)
Status: Archived
Updated: 1/1/1970
Mary Crowley Cancer Research Center
mi
from
Dallas, TX
Non-Treatment Study of Factors Affecting Cocaine Drug Choice
Human Laboratory Model of Cocaine Treatment: Behavioral Economic Analysis: Study 1
Status: Archived
Wayne State University
mi
from
Detroit, MI
Non-Treatment Study of Factors Affecting Cocaine Drug Choice
Human Laboratory Model of Cocaine Treatment: Behavioral Economic Analysis: Study 1
Status: Archived
Updated: 1/1/1970
Wayne State University
mi
from
Detroit, MI
AntiCoagulant Effectiveness in Idiopathic Pulmonary Fibrosis
AntiCoagulant Effectiveness in Idiopathic Pulmonary Fibrosis (ACE-IPF)
Status: Archived
University of Alabama - Birmingham
mi
from
Birmingham, AL
AntiCoagulant Effectiveness in Idiopathic Pulmonary Fibrosis
AntiCoagulant Effectiveness in Idiopathic Pulmonary Fibrosis (ACE-IPF)
Status: Archived
Updated: 1/1/1970
University of Alabama - Birmingham
mi
from
Birmingham, AL
AntiCoagulant Effectiveness in Idiopathic Pulmonary Fibrosis
AntiCoagulant Effectiveness in Idiopathic Pulmonary Fibrosis (ACE-IPF)
Status: Archived
UCLA Medical Center
mi
from
Los Angeles, CA
AntiCoagulant Effectiveness in Idiopathic Pulmonary Fibrosis
AntiCoagulant Effectiveness in Idiopathic Pulmonary Fibrosis (ACE-IPF)
Status: Archived
Updated: 1/1/1970
UCLA Medical Center
mi
from
Los Angeles, CA
AntiCoagulant Effectiveness in Idiopathic Pulmonary Fibrosis
AntiCoagulant Effectiveness in Idiopathic Pulmonary Fibrosis (ACE-IPF)
Status: Archived
University of California - San Francisco
mi
from
San Francisco, CA
AntiCoagulant Effectiveness in Idiopathic Pulmonary Fibrosis
AntiCoagulant Effectiveness in Idiopathic Pulmonary Fibrosis (ACE-IPF)
Status: Archived
Updated: 1/1/1970
University of California - San Francisco
mi
from
San Francisco, CA
AntiCoagulant Effectiveness in Idiopathic Pulmonary Fibrosis
AntiCoagulant Effectiveness in Idiopathic Pulmonary Fibrosis (ACE-IPF)
Status: Archived
National Jewish Medical and Research Center
mi
from
Denver, CO
AntiCoagulant Effectiveness in Idiopathic Pulmonary Fibrosis
AntiCoagulant Effectiveness in Idiopathic Pulmonary Fibrosis (ACE-IPF)
Status: Archived
Updated: 1/1/1970
National Jewish Medical and Research Center
mi
from
Denver, CO
AntiCoagulant Effectiveness in Idiopathic Pulmonary Fibrosis
AntiCoagulant Effectiveness in Idiopathic Pulmonary Fibrosis (ACE-IPF)
Status: Archived
Yale University School of Medicine
mi
from
New Haven, CT
AntiCoagulant Effectiveness in Idiopathic Pulmonary Fibrosis
AntiCoagulant Effectiveness in Idiopathic Pulmonary Fibrosis (ACE-IPF)
Status: Archived
Updated: 1/1/1970
Yale University School of Medicine
mi
from
New Haven, CT
AntiCoagulant Effectiveness in Idiopathic Pulmonary Fibrosis
AntiCoagulant Effectiveness in Idiopathic Pulmonary Fibrosis (ACE-IPF)
Status: Archived
University of Miami Hospital
mi
from
Miami, FL
AntiCoagulant Effectiveness in Idiopathic Pulmonary Fibrosis
AntiCoagulant Effectiveness in Idiopathic Pulmonary Fibrosis (ACE-IPF)
Status: Archived
Updated: 1/1/1970
University of Miami Hospital
mi
from
Miami, FL
AntiCoagulant Effectiveness in Idiopathic Pulmonary Fibrosis
AntiCoagulant Effectiveness in Idiopathic Pulmonary Fibrosis (ACE-IPF)
Status: Archived
University of Chicago
mi
from
Chicago, IL
AntiCoagulant Effectiveness in Idiopathic Pulmonary Fibrosis
AntiCoagulant Effectiveness in Idiopathic Pulmonary Fibrosis (ACE-IPF)
Status: Archived
Updated: 1/1/1970
University of Chicago
mi
from
Chicago, IL
AntiCoagulant Effectiveness in Idiopathic Pulmonary Fibrosis
AntiCoagulant Effectiveness in Idiopathic Pulmonary Fibrosis (ACE-IPF)
Status: Archived
University of Louisville Hospital
mi
from
Louisville, KY
AntiCoagulant Effectiveness in Idiopathic Pulmonary Fibrosis
AntiCoagulant Effectiveness in Idiopathic Pulmonary Fibrosis (ACE-IPF)
Status: Archived
Updated: 1/1/1970
University of Louisville Hospital
mi
from
Louisville, KY
AntiCoagulant Effectiveness in Idiopathic Pulmonary Fibrosis
AntiCoagulant Effectiveness in Idiopathic Pulmonary Fibrosis (ACE-IPF)
Status: Archived
Tulane University Medical Center
mi
from
New Orleans, LA
AntiCoagulant Effectiveness in Idiopathic Pulmonary Fibrosis
AntiCoagulant Effectiveness in Idiopathic Pulmonary Fibrosis (ACE-IPF)
Status: Archived
Updated: 1/1/1970
Tulane University Medical Center
mi
from
New Orleans, LA
AntiCoagulant Effectiveness in Idiopathic Pulmonary Fibrosis
AntiCoagulant Effectiveness in Idiopathic Pulmonary Fibrosis (ACE-IPF)
Status: Archived
University of Michigan Health Systems
mi
from
Ann Arbor, MI
AntiCoagulant Effectiveness in Idiopathic Pulmonary Fibrosis
AntiCoagulant Effectiveness in Idiopathic Pulmonary Fibrosis (ACE-IPF)
Status: Archived
Updated: 1/1/1970
University of Michigan Health Systems
mi
from
Ann Arbor, MI
AntiCoagulant Effectiveness in Idiopathic Pulmonary Fibrosis
AntiCoagulant Effectiveness in Idiopathic Pulmonary Fibrosis (ACE-IPF)
Status: Archived
Mayo Clinic Rochester
mi
from
Rochester, MN
AntiCoagulant Effectiveness in Idiopathic Pulmonary Fibrosis
AntiCoagulant Effectiveness in Idiopathic Pulmonary Fibrosis (ACE-IPF)
Status: Archived
Updated: 1/1/1970
Mayo Clinic Rochester
mi
from
Rochester, MN
AntiCoagulant Effectiveness in Idiopathic Pulmonary Fibrosis
AntiCoagulant Effectiveness in Idiopathic Pulmonary Fibrosis (ACE-IPF)
Status: Archived
ST. Luke's Hospital
mi
from
Kansas City, MO
AntiCoagulant Effectiveness in Idiopathic Pulmonary Fibrosis
AntiCoagulant Effectiveness in Idiopathic Pulmonary Fibrosis (ACE-IPF)
Status: Archived
Updated: 1/1/1970
ST. Luke's Hospital
mi
from
Kansas City, MO
AntiCoagulant Effectiveness in Idiopathic Pulmonary Fibrosis
AntiCoagulant Effectiveness in Idiopathic Pulmonary Fibrosis (ACE-IPF)
Status: Archived
Cornell University, Weill Medical College
mi
from
New York, NY
AntiCoagulant Effectiveness in Idiopathic Pulmonary Fibrosis
AntiCoagulant Effectiveness in Idiopathic Pulmonary Fibrosis (ACE-IPF)
Status: Archived
Updated: 1/1/1970
Cornell University, Weill Medical College
mi
from
New York, NY
AntiCoagulant Effectiveness in Idiopathic Pulmonary Fibrosis
AntiCoagulant Effectiveness in Idiopathic Pulmonary Fibrosis (ACE-IPF)
Status: Archived
Highland Hospital
mi
from
Oakland, CA
AntiCoagulant Effectiveness in Idiopathic Pulmonary Fibrosis
AntiCoagulant Effectiveness in Idiopathic Pulmonary Fibrosis (ACE-IPF)
Status: Archived
Updated: 1/1/1970
Highland Hospital
mi
from
Oakland, CA
AntiCoagulant Effectiveness in Idiopathic Pulmonary Fibrosis
AntiCoagulant Effectiveness in Idiopathic Pulmonary Fibrosis (ACE-IPF)
Status: Archived
Duke Univ Med Ctr
mi
from
Durham, NC
AntiCoagulant Effectiveness in Idiopathic Pulmonary Fibrosis
AntiCoagulant Effectiveness in Idiopathic Pulmonary Fibrosis (ACE-IPF)
Status: Archived
Updated: 1/1/1970
Duke Univ Med Ctr
mi
from
Durham, NC
AntiCoagulant Effectiveness in Idiopathic Pulmonary Fibrosis
AntiCoagulant Effectiveness in Idiopathic Pulmonary Fibrosis (ACE-IPF)
Status: Archived
Cleveland Clinic Florida
mi
from
Weston, FL
AntiCoagulant Effectiveness in Idiopathic Pulmonary Fibrosis
AntiCoagulant Effectiveness in Idiopathic Pulmonary Fibrosis (ACE-IPF)
Status: Archived
Updated: 1/1/1970
Cleveland Clinic Florida
mi
from
Weston, FL
AntiCoagulant Effectiveness in Idiopathic Pulmonary Fibrosis
AntiCoagulant Effectiveness in Idiopathic Pulmonary Fibrosis (ACE-IPF)
Status: Archived
Hospital of the University of Pennsylvania
mi
from
Philadelphia, PA
AntiCoagulant Effectiveness in Idiopathic Pulmonary Fibrosis
AntiCoagulant Effectiveness in Idiopathic Pulmonary Fibrosis (ACE-IPF)
Status: Archived
Updated: 1/1/1970
Hospital of the University of Pennsylvania
mi
from
Philadelphia, PA
AntiCoagulant Effectiveness in Idiopathic Pulmonary Fibrosis
AntiCoagulant Effectiveness in Idiopathic Pulmonary Fibrosis (ACE-IPF)
Status: Archived
Medical University of South Carolina
mi
from
Charleston, SC
AntiCoagulant Effectiveness in Idiopathic Pulmonary Fibrosis
AntiCoagulant Effectiveness in Idiopathic Pulmonary Fibrosis (ACE-IPF)
Status: Archived
Updated: 1/1/1970
Medical University of South Carolina
mi
from
Charleston, SC
AntiCoagulant Effectiveness in Idiopathic Pulmonary Fibrosis
AntiCoagulant Effectiveness in Idiopathic Pulmonary Fibrosis (ACE-IPF)
Status: Archived
Vanderbilt University Medical Center
mi
from
Ventura, CA
AntiCoagulant Effectiveness in Idiopathic Pulmonary Fibrosis
AntiCoagulant Effectiveness in Idiopathic Pulmonary Fibrosis (ACE-IPF)
Status: Archived
Updated: 1/1/1970
Vanderbilt University Medical Center
mi
from
Ventura, CA
AntiCoagulant Effectiveness in Idiopathic Pulmonary Fibrosis
AntiCoagulant Effectiveness in Idiopathic Pulmonary Fibrosis (ACE-IPF)
Status: Archived
UT Soutwestern Medical Center at Dallas
mi
from
Dallas, TX
AntiCoagulant Effectiveness in Idiopathic Pulmonary Fibrosis
AntiCoagulant Effectiveness in Idiopathic Pulmonary Fibrosis (ACE-IPF)
Status: Archived
Updated: 1/1/1970
UT Soutwestern Medical Center at Dallas
mi
from
Dallas, TX
AntiCoagulant Effectiveness in Idiopathic Pulmonary Fibrosis
AntiCoagulant Effectiveness in Idiopathic Pulmonary Fibrosis (ACE-IPF)
Status: Archived
University of Utah
mi
from
Salt Lake City, UT
AntiCoagulant Effectiveness in Idiopathic Pulmonary Fibrosis
AntiCoagulant Effectiveness in Idiopathic Pulmonary Fibrosis (ACE-IPF)
Status: Archived
Updated: 1/1/1970
University of Utah
mi
from
Salt Lake City, UT
AntiCoagulant Effectiveness in Idiopathic Pulmonary Fibrosis
AntiCoagulant Effectiveness in Idiopathic Pulmonary Fibrosis (ACE-IPF)
Status: Archived
University of Washington
mi
from
Seattle, WA
AntiCoagulant Effectiveness in Idiopathic Pulmonary Fibrosis
AntiCoagulant Effectiveness in Idiopathic Pulmonary Fibrosis (ACE-IPF)
Status: Archived
Updated: 1/1/1970
University of Washington
mi
from
Seattle, WA
Role of Endorphins in Perception of Dyspnea With Resistive Loading in Chronic Obstructive Pulmonary Disease (COPD)
The Role of Endorphins in the Perception of Dyspnea With Resistive Loading in Patients With COPD
Status: Archived
Darien Pediatric Associates
mi
from
Darien, CT
Role of Endorphins in Perception of Dyspnea With Resistive Loading in Chronic Obstructive Pulmonary Disease (COPD)
The Role of Endorphins in the Perception of Dyspnea With Resistive Loading in Patients With COPD
Status: Archived
Updated: 1/1/1970
Darien Pediatric Associates
mi
from
Darien, CT
STIP: Statin Trial for Influenza Patients
Randomized, Placebo Controlled Trial of the Effectiveness of Statins for Preventing Mortality Following ICU Admission for Influenza Complications
Status: Archived
University of Arkansas
mi
from
Little Rock, AR
STIP: Statin Trial for Influenza Patients
Randomized, Placebo Controlled Trial of the Effectiveness of Statins for Preventing Mortality Following ICU Admission for Influenza Complications
Status: Archived
Updated: 1/1/1970
University of Arkansas
mi
from
Little Rock, AR